398 related articles for article (PubMed ID: 27860138)
21. Single-arm phase II trial design under parametric cure models.
Wu J
Pharm Stat; 2015; 14(3):226-32. PubMed ID: 25846141
[TBL] [Abstract][Full Text] [Related]
22. Sample size computation for two-sample noninferiority log-rank test.
Jung SH; Kang SJ; McCall LM; Blumenstein B
J Biopharm Stat; 2005; 15(6):969-79. PubMed ID: 16279355
[TBL] [Abstract][Full Text] [Related]
23. A practical comparison of blinded methods for sample size reviews in survival data clinical trials.
Todd S; Valdés-Márquez E; West J
Pharm Stat; 2012; 11(2):141-8. PubMed ID: 22337635
[TBL] [Abstract][Full Text] [Related]
24. Quantifying treatment differences in confirmatory trials under non-proportional hazards.
Jiménez JL
J Appl Stat; 2022; 49(2):466-484. PubMed ID: 35707213
[TBL] [Abstract][Full Text] [Related]
25. A clinical trial design using the concept of proportional time using the generalized gamma ratio distribution.
Phadnis MA; Wetmore JB; Mayo MS
Stat Med; 2017 Nov; 36(26):4121-4140. PubMed ID: 28815655
[TBL] [Abstract][Full Text] [Related]
26. The large sample distribution of the weighted log rank statistic under general local alternatives.
Ewell M; Ibrahim JG
Lifetime Data Anal; 1997; 3(1):5-12. PubMed ID: 9384622
[TBL] [Abstract][Full Text] [Related]
27. Statistical and practical considerations in designing of immuno-oncology trials.
Mukhopadhyay P; Huang W; Metcalfe P; Öhrn F; Jenner M; Stone A
J Biopharm Stat; 2020 Nov; 30(6):1130-1146. PubMed ID: 33706684
[TBL] [Abstract][Full Text] [Related]
28. Sample size calculation for the one-sample log-rank test.
Wu J
Pharm Stat; 2015; 14(1):26-33. PubMed ID: 25339496
[TBL] [Abstract][Full Text] [Related]
29. Combining stratified and unstratified log-rank tests in paired survival data.
Oakes D; Feng C
Stat Med; 2010 Jul; 29(16):1735-45. PubMed ID: 20572124
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints.
Beisel C; Benner A; Kunz C; Kopp-Schneider A
Biom J; 2017 May; 59(3):511-530. PubMed ID: 28263395
[TBL] [Abstract][Full Text] [Related]
31. NPHMC: an R-package for estimating sample size of proportional hazards mixture cure model.
Cai C; Wang S; Lu W; Zhang J
Comput Methods Programs Biomed; 2014; 113(1):290-300. PubMed ID: 24199658
[TBL] [Abstract][Full Text] [Related]
32. Sample size calculation for comparing two negative binomial rates.
Zhu H; Lakkis H
Stat Med; 2014 Feb; 33(3):376-87. PubMed ID: 24038204
[TBL] [Abstract][Full Text] [Related]
33. Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.
Royston P; Parmar MK
BMC Med Res Methodol; 2016 Feb; 16():16. PubMed ID: 26869168
[TBL] [Abstract][Full Text] [Related]
34. Design and analysis of clinical trials in the presence of delayed treatment effect.
Sit T; Liu M; Shnaidman M; Ying Z
Stat Med; 2016 May; 35(11):1774-9. PubMed ID: 26833957
[TBL] [Abstract][Full Text] [Related]
35. Complex survival trial design by the product integration method.
Tang Y
Stat Med; 2022 Feb; 41(4):798-814. PubMed ID: 34908180
[TBL] [Abstract][Full Text] [Related]
36. A log rank type test in observational survival studies with stratified sampling.
Bai X; Tsiatis AA
Lifetime Data Anal; 2016 Apr; 22(2):280-98. PubMed ID: 26025499
[TBL] [Abstract][Full Text] [Related]
37. Sequential tests for non-proportional hazards data.
Brückner M; Brannath W
Lifetime Data Anal; 2017 Jul; 23(3):339-352. PubMed ID: 26969674
[TBL] [Abstract][Full Text] [Related]
38. Sample sizes based on the log-rank statistic in complex clinical trials.
Lakatos E
Biometrics; 1988 Mar; 44(1):229-41. PubMed ID: 3358991
[TBL] [Abstract][Full Text] [Related]
39. Designing cancer immunotherapy trials with delayed treatment effect using maximin efficiency robust statistics.
Ding X; Wu J
Pharm Stat; 2020 Jul; 19(4):424-435. PubMed ID: 32090453
[TBL] [Abstract][Full Text] [Related]
40. Power and sample size calculation for log-rank test with a time lag in treatment effect.
Zhang D; Quan H
Stat Med; 2009 Feb; 28(5):864-79. PubMed ID: 19152230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
